LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc?

Are Capita plc (LON:CPI) and AstraZeneca plc (LON:AZN) poor investments today?

Read more »

Investing Articles

3 top picks for a 2017 starter portfolio

Here are three shares that could make a great start to your investing career.

Read more »

Investing Articles

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Neil Woodford’s favourite stock set to outperform in 2017?

Neil Woodford loves this company, but should you be buying?

Read more »

Investing Articles

2 healthcare stocks that could make you rich in 2017

These two companies offer bright futures at fair valuations.

Read more »

Investing Articles

My 3 top dividend stocks for Christmas

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year.

Read more »

Investing Articles

Why Eco Animal Health Group Plc is set to outperform AstraZeneca plc in 2017

Eco Animal Health Group Plc (LON: EAH) has more appeal than AstraZeneca plc (LON: EAH).

Read more »

Investing Articles

Why I believe these 3 stocks will struggle in 2017

These three companies are in danger of generating losses for investors next year.

Read more »

Investing Articles

3 cheap blue chips for December

Are these Footsie favourites now unmissable bargains?

Read more »

Investing Articles

4 dividend stocks to put on your 2017 shopping list

Royston Wild reveals a cluster of London stocks with exceptional dividend potential.

Read more »

Investing Articles

Is ReNeuron Group plc a better buy than AstraZeneca plc?

Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)?

Read more »

Investing Articles

These 3 FTSE 100 stocks are ridiculously cheap!

Royston Wild discusses three FTSE 100 (INDEXFTSE: UKX) dealing at rock-bottom prices.

Read more »